Economic impact of same-day home discharge after uncomplicated transradial percutaneous coronary intervention and bolus-only abciximab regimen

JACC: Cardiovascular Interventions

Volumn 3, Issue 10, 2010, Pages 1011-1019

  Rinfret, Stphane ^a   Kennedy, Wendy Ann ^b   Lachaine, Jean ^c   Lemay, Anne ^c   Rods Cabau, Josep ^a   Cohen, David J ^d   Costerousse, Olivier ^a   Bertrand, Olivier F ^a  

^a LAVAL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

cost; percutaneous coronary intervention; same day discharge; transradial

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HOME CARE; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACUTE CORONARY SYNDROME; AMBULATORY CARE; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; COST SAVINGS; COST-BENEFIT ANALYSIS; DRUG COSTS; HEALTH CARE COSTS; HOSPITAL COSTS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LENGTH OF STAY; MODELS, ECONOMIC; PATIENT DISCHARGE; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; QUEBEC; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77958572419     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.07.011     Document Type: Article

References (17)

1. Treating heart ailments costs $78 billion AHRQ News and Numbers, March 25, 2009. Agency for Healthcare Research and Quality, Rockville, MD http://www.ahrq.gov/news/nn/nn032509.htm Accessed September 15, 2010
2. N.Z. Ahmad, G. Byrnes, and S.A. Naqvi A meta-analysis of ambulatory versus inpatient laparoscopic cholecystectomy Surg Endosc 22 2008 1928 1934
3. J.L. Edwards Diagnosis and management of benign prostatic hyperplasia Am Fam Physician 77 2008 1403 1410
4. O.F. Bertrand, R. De Larochelliere, J. Rodes-Cabau Discharge After Transradial Stenting of Coronary Arteries Study Investigators A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation Circulation 114 2006 2636 2643
5. A. Jeremias, D.S. Baim, and K.K. Ho Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures J Am Coll Cardiol 44 2004 1210 1214
6. S.S. Jolly, S. Amlani, M. Hamon, S. Yusuf, and S.R. Mehta Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials Am Heart J 157 2009 132 140
7. G.S. Heyde, K.T. Koch, and R.J. de Winter Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS) Circulation 115 2007 2299 2306
8. R. Jabara, R. Gadesam, and L. Pendyala Ambulatory discharge after transradial coronary intervention: preliminary US single-center experience (Same-day TransRadial Intervention and Discharge Evaluation, the STRIDE Study) Am Heart J 156 2008 1141 1146
9. A. Lemay, M.-C. Poulin, J. Carle, and R. Bilodeau Une evaluation novatrice de la qualit-perfomance de la gestion du medicament dans un CHU Ruptures 10 2005 28 43
10. S. Rinfret, D.J. Cohen, A.A. Tahami Monfared, J. Lelorier, J. Mireault, and E. Schampaert Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial Am J Cardiovasc Drugs 6 2006 159 168
11. Statistics Canada http://www40.statcan.gc.ca/l01/cst01/econ161a-eng.htm? sdi=consumer%20price%20index%20health%20care Accessed September 15, 2010
12. Manuels: Manuel de facturation http://www.ramq.gouv.qc.ca/fr/ professionnels/medspe/manuel/man150.shtml Accessed September 15, 2010
13. J.A. Doshi, H.A. Glick, and D. Polsky Analyses of cost data in economic evaluations conducted alongside randomized controlled trials Value Health 9 2006 334 340
14. A.M. Lincoff, J.A. Bittl, R.A. Harrington REPLACE-2 Investigators Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 2003 853 863
15. G.W. Stone, B.T. McLaurin, D.A. Cox ACUITY Investigators Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
16. Agency for Healthcare Research and Quality HCUP facts and figures, 2006; statistics on hospital-based care in the United States http://www.hcup-us.ahrq. gov/reports/factsandfigures/facts-figures-2006.jsp#section2 Accessed April 9, 2009
17. S.V. Manoukian, F. Feit, and R. Mehran Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial J Am Coll Cardiol 49 2007 1362 1368